Maria E. Pasquale - 30 Jan 2023 Form 4 Insider Report for INCYTE CORP (INCY)

Role
EVP & General Counsel
Signature
/s/ Elizabeth Feeney, Attorney-In-Fact
Issuer symbol
INCY
Transactions as of
30 Jan 2023
Net transactions value
-$681,345
Form type
4
Filing time
01 Feb 2023, 15:00:11 UTC
Previous filing
24 Jan 2023
Next filing
02 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INCY Common Stock Options Exercise $840,856 +12,865 +19% $65.36 81,389 30 Jan 2023 Direct
transaction INCY Common Stock Sale $1,089,537 -12,865 -16% $84.69 68,524 30 Jan 2023 Direct F1
transaction INCY Common Stock Options Exercise $716,256 +10,438 +15% $68.62 78,962 30 Jan 2023 Direct
transaction INCY Common Stock Sale $884,099 -10,438 -13% $84.70 68,524 30 Jan 2023 Direct F1
transaction INCY Common Stock Options Exercise $857,194 +11,861 +17% $72.27 80,385 30 Jan 2023 Direct
transaction INCY Common Stock Sale $1,004,627 -11,861 -15% $84.70 68,524 30 Jan 2023 Direct F1
transaction INCY Common Stock Options Exercise $1,157,107 +14,374 +21% $80.50 82,898 30 Jan 2023 Direct
transaction INCY Common Stock Sale $1,217,909 -14,374 -17% $84.73 68,524 30 Jan 2023 Direct F1
transaction INCY Common Stock Options Exercise $471,726 +5,644 +8.2% $83.58 74,168 30 Jan 2023 Direct
transaction INCY Common Stock Sale $480,135 -5,644 -7.6% $85.07 68,524 30 Jan 2023 Direct F1
transaction INCY Common Stock Options Exercise $362,085 +4,842 +7.1% $74.78 73,366 30 Jan 2023 Direct
transaction INCY Common Stock Sale $410,263 -4,842 -6.6% $84.73 68,524 30 Jan 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INCY Non-Qualified Stock Option (right to buy) Options Exercise $0 -12,865 -100% $0.000000* 0 30 Jan 2023 Common Stock 12,865 $65.36 Direct F3
transaction INCY Non-Qualified Stock Option (right to buy) Options Exercise $0 -10,438 -100% $0.000000* 0 30 Jan 2023 Common Stock 10,438 $68.62 Direct F4
transaction INCY Non-Qualified Stock Option (right to buy) Options Exercise $0 -11,861 -100% $0.000000* 0 30 Jan 2023 Common Stock 11,861 $72.27 Direct F5
transaction INCY Non-Qualified Stock Option (right to buy) Options Exercise $0 -14,374 -100% $0.000000* 0 30 Jan 2023 Common Stock 14,374 $80.50 Direct F6
transaction INCY Non-Qualified Stock Option (right to buy) Options Exercise $0 -5,644 -100% $0.000000* 0 30 Jan 2023 Common Stock 5,644 $83.58 Direct F7
transaction INCY Non-Qualified Stock Option (right to buy) Options Exercise $0 -4,842 -100% $0.000000* 0 30 Jan 2023 Common Stock 4,842 $74.78 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
F2 Includes an aggregate of 49,571 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
F3 Beginning April 9, 2018, options become exercisable in 37 installments, with the first 25% vesting on April 9, 2019 and the remainder vesting monthly over three years.
F4 Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years.
F5 Beginning January 4, 2019, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years.
F6 Beginning January 17, 2020, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2020 and the remainder vesting monthly over three years.
F7 Beginning July 2, 2021, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2022 and the remainder vesting monthly over three years.
F8 Beginning January 2, 2022, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2022 and the remainder vesting monthly over three years.